The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...
Amgen has made waves in the biosimilar field in recent years with its U.S.-first Humira biosim launch last year and its ...
Amgen Inc. (NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. Analysts ...
Moderna's RSV shot is the first messenger RNA-based (mRNA) vaccine not for COVID-19 to be approved in the United States. It ...
Natco Pharma faces lawsuit from Pfizer over generic migraine drug, potential 180-day exclusivity for Rimegepant Sulfate ...
The U.S. Food and Drug Administration on Monday approved Biocon unit's biosimilar to Regeneron Pharmaceuticals' blockbuster ...
Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the ...
Amgen to present innovative research from its robust oncology portfolio at ASCO 2024: Thousand Oaks, California Thursday, May 30, 2024, 18:00 Hrs [IST] Amgen announced the present ...
Alembic Pharmaceuticals said that has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Sacubitril and Valsartan Tablets.
Biocon Biologics said on Tuesday the US Food and Drug Administration (US FDA) has approved the Indian group’s first-to-file ...
So far only three GLP-1 drugs have been approved to treat obese or overweight individuals: liraglutide and semaglutide, ...
Biocon Biologics announced that the US Food and Drug Administration (US FDA) has approved the company's application for ...